INS and metabolic disease: IR, which is characterized by compensatory insulin secretion mediated by pancreatic β-cells and a decreased response of multiple insulin-responsive target organs, is a metabolic disease involving multiple organs including insulin-secreting organs and insulin-responsive target organs 7.